Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
FUJIFILM Holdings Corporation (4901.T)
Tokyo, JP
FUJIFILM Holdings Corporation is a global enterprise dedicated to the development, manufacturing, sales, and servicing of an extensive range of solutions, categorized into imaging, healthcare, materials, and business innovation. Its Healthcare division provides a comprehensive suite of products and services designed for prevention, diagnosis, and treatment. These offerings include medical devices, biomedical contract development and manufacturing organization (CDMO) services, pharmaceuticals, regenerative medicine, and cosmetics and dietary supplements. The Materials segment focuses on industrial applications, supplying inkjet digital presses and printing plates for the printing sector, along with industrial inkjet products and print heads. It also offers data storage media and archiving solutions for digital information management, as well as advanced materials for displays, touch panels, semiconductors, image sensors, and functional films. Within the Business Innovation segment, the company delivers office-oriented devices and services, such as digital multifunction machines, printers, software, and cloud-based solutions. It further provides workflow optimization tools for graphical communications companies and offers tailored document services, including system integration and business process outsourcing, to meet diverse business requirements. The Imaging segment covers both traditional photography and advanced optical technologies. It features products like color films, instant cameras, photo developing and printing systems, color papers, and photo printing services. Additionally, this segment produces high-quality optics, including lenses for TV and cinema production, surveillance cameras, industrial inspection, and projectors. Founded in 1934, FUJIFILM Holdings Corporation is headquartered in Tokyo, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.92% | +8.95% | +3.24% | +6.13% | -4.14% | -5.32% | -3.94% | +24.14% | +39.94% | +115.37% | +129.93% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 5 | 0 |
| Hold | 5 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Devices: +11.2%+5.0% Q1'26: +6.8% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%+6.0% Q1'26: +4.8% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%+6.1% Q1'26: +4.4% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%+10.4% ★ Q1'26: +11.0% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%+5.6% ★ Q1'26: +7.0% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+0.2% Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×1.97× Q1'26: 2.52× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 14 Rev. Ana. 14 EPS Ana. |
Mar 2027 10 Rev. Ana. 11 EPS Ana. |
Mar 2028 12 Rev. Ana. 12 EPS Ana. |
Mar 2029 2 Rev. Ana. 2 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
Mar 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.49T
est: 2.50T (-0.4%)
|
2.49T
est: 2.55T (-2.2%)
|
2.32T
est: 2.37T (-2.0%)
|
2.43T
est: 2.45T (-0.9%)
|
2.43T
est: 2.45T (-0.7%)
|
2.32T
est: 2.34T (-1.1%)
|
2.19T
est: 2.18T (+0.4%)
|
2.53T
est: 2.51T (+0.5%)
|
2.86T
est: 2.79T (+2.5%)
|
2.96T
est: 3.05T (-2.9%)
|
3.20T
est: 3.15T (+1.5%)
|
3.31T
3.27T – 3.32T
+5.0% YoY
|
3.47T
3.40T – 3.61T
+5.0% YoY
|
3.64T
3.64T – 3.64T
+4.8% YoY
|
3.84T
3.82T – 3.86T
+5.6% YoY
|
4.02T
3.94T – 4.18T
+4.7% YoY
|
4.26T
4.18T – 4.43T
+5.9% YoY
|
| EBITDA |
290.82B
est: 363.12B (-19.9%)
|
305.59B
est: 369.52B (-17.3%)
|
289.92B
est: 343.68B (-15.6%)
|
258.32B
est: 356.00B (-27.4%)
|
339.76B
est: 355.07B (-4.3%)
|
309.22B
est: 339.61B (-8.9%)
|
288.90B
est: 316.62B (-8.8%)
|
362.70B
est: 364.66B (-0.5%)
|
415.29B
est: 404.57B (+2.6%)
|
426.74B
est: 539.31B (-20.9%)
|
493.72B
est: 556.94B (-11.4%)
|
585.03B
577.74B – 587.22B
+5.0% YoY
|
614.37B
601.83B – 637.67B
+5.0% YoY
|
644.03B
643.59B – 644.46B
+4.8% YoY
|
679.84B
676.47B – 683.22B
+5.6% YoY
|
711.90B
697.37B – 738.89B
+4.7% YoY
|
754.22B
738.82B – 782.82B
+5.9% YoY
|
| EBIT |
164.42B
est: 232.67B (-29.3%)
|
180.63B
est: 236.77B (-23.7%)
|
172.28B
est: 220.22B (-21.8%)
|
130.68B
est: 228.11B (-42.7%)
|
209.83B
est: 227.52B (-7.8%)
|
186.57B
est: 217.61B (-14.3%)
|
165.47B
est: 202.87B (-18.4%)
|
229.70B
est: 233.66B (-1.7%)
|
273.08B
est: 259.23B (+5.3%)
|
276.73B
est: 401.00B (-31.0%)
|
330.16B
est: 414.11B (-20.3%)
|
434.99B
429.57B – 436.62B
+5.0% YoY
|
456.81B
447.48B – 474.13B
+5.0% YoY
|
478.86B
478.54B – 479.18B
+4.8% YoY
|
505.49B
502.98B – 508.00B
+5.6% YoY
|
529.32B
518.52B – 549.40B
+4.7% YoY
|
560.79B
549.34B – 582.06B
+5.9% YoY
|
| Net Income |
118.55B
est: 93.86B (+26.3%)
|
123.31B
est: 103.71B (+18.9%)
|
131.51B
est: 103.55B (+27.0%)
|
140.69B
est: 127.02B (+10.8%)
|
138.11B
est: 126.63B (+9.1%)
|
124.99B
est: 152.11B (-17.8%)
|
181.21B
est: 164.33B (+10.3%)
|
211.18B
est: 187.08B (+12.9%)
|
219.42B
est: 202.69B (+8.3%)
|
243.51B
est: 249.83B (-2.5%)
|
260.95B
est: 253.99B (+2.7%)
|
267.23B
255.92B – 275.19B
+5.2% YoY
|
272.96B
263.91B – 289.21B
+2.1% YoY
|
318.20B
290.46B – 343.13B
+16.6% YoY
|
346.65B
342.31B – 351.00B
+8.9% YoY
|
378.90B
368.85B – 397.58B
+9.3% YoY
|
476.24B
463.61B – 499.72B
+25.7% YoY
|
| SGA |
627.97B
est: 633.57B (-0.9%)
|
622.42B
est: 644.73B (-3.5%)
|
598.13B
est: 599.65B (-0.3%)
|
673.00B
est: 621.15B (+8.3%)
|
631.56B
est: 619.53B (+1.9%)
|
610.04B
est: 592.56B (+3.0%)
|
552.07B
est: 552.43B (-0.1%)
|
653.00B
est: 636.25B (+2.6%)
|
710.70B
est: 705.90B (+0.7%)
|
752.43B
est: 771.68B (-2.5%)
|
806.53B
est: 796.91B (+1.2%)
|
837.09B
826.66B – 840.23B
+5.0% YoY
|
879.08B
861.14B – 912.42B
+5.0% YoY
|
921.51B
920.89B – 922.13B
+4.8% YoY
|
972.76B
967.93B – 977.59B
+5.6% YoY
|
1.02T
997.84B – 1.06T
+4.7% YoY
|
1.08T
1.06T – 1.12T
+5.9% YoY
|
| EPS |
245.94
est: 78.00 (+215.3%)
|
250.03
est: 86.19 (+190.1%)
|
296.27
est: 86.06 (+244.3%)
|
322.62
est: 105.57 (+205.6%)
|
114.81
est: 105.24 (+9.1%)
|
102.06
est: 126.41 (-19.3%)
|
151.09
est: 136.57 (+10.6%)
|
175.81
est: 155.48 (+13.1%)
|
182.40
est: 169.30 (+7.7%)
|
201.90
est: 207.67 (-2.8%)
|
216.86
est: 206.35 (+5.1%)
|
221.59
212.69 – 228.71
+7.4% YoY
|
231.96
219.34 – 240.36
+4.7% YoY
|
265.54
241.40 – 285.17
+14.5% YoY
|
288.10
284.49 – 291.71
+8.5% YoY
|
314.90
306.55 – 330.42
+9.3% YoY
|
395.80
385.30 – 415.31
+25.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-01 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 3/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-15 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kenji Sukeno | Executive Chairman of The Board | 158M | male |
| Teiichi Goto | President, Chief Executive Officer & Director | 136M | male |
| Shigetaka Komori | Executive Advisor | 129M | male |
| Chisato Yoshizawa | Corporate Vice President, GM of Corp Communications and ESG Division-Global Audit Dep, Brand Mgmt & Director | 40M | female |
| Masayuki Higuchi | Corporate Vice President, GM of Corporate Planning Division, Accounting and Finance Div, Chief Financial Officer & Director | 40M | male |
| Yasushi Zama | Corporate Vice President and GM of Human Resources Division & Corporate General Administration Division | — | — |
| Kazuhisa Horikiri | Corporate Vice President & GM of Design Strategy Office | — | — |
| Naoko Sakuma | Corporate Vice President & GM of Intellectual Property Division | — | — |
| Seigo Sugimoto | Corporate Vice President, Chief Digital Officer & GM of ICT Strategy Office | — | — |
| Atsushi Sakurai | Corporate Vice President & GM of Legal Division | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4901.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
